Search

everythinglearnresearchcommunity

for

Search:↓

Hair regrowth improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

Non-blinded assessors tend to overestimate effects in trials by about 29%.

No medications for alcohol dependence have been approved for marketing yet.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Natural ingredients can improve skin and hair, but more research is needed.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Dupilumab effectively improves skin conditions, reduces symptoms, and enhances quality of life in certain dermatological issues.

Guselkumab significantly improves quality of life for people with moderate to severe psoriasis.

PRP is unlikely to effectively treat wrist ganglia.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Topical latanoprost acid at 0.05% concentration improved hair growth in women with androgenetic alopecia.

Mesenchymal stem cell-derived exosomes show promise for treating skin and tissue diseases.

Centella asiatica with growth factors improves hair and scalp health.

Both 2.5 mg and 5 mg doses of oral minoxidil are effective for hair regrowth in men with hair loss.

PRP is a good alternative or addition to minoxidil for treating hair loss.

5% ET-02 is a more effective and safe treatment for hair loss than current options.

The 5 mg dose of oral minoxidil is not more effective than the 2.5 mg dose for treating male hair loss.

Creatine does not cause hair loss.

JAK inhibitors effectively regrow hair in children with alopecia areata and are safe to use.

Dermocosmetics significantly reduce itch and skin sensitivity in atopic dermatitis patients.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.

Regenerative medicine shows promise for treating skin disorders like hair loss and vitiligo.

Stem cell therapies show promise for hair regrowth in androgenetic alopecia.

Psychological interventions can improve the quality of life for women with PCOS.

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.

Metatrials could improve clinical research in nephrology by speeding up data collection and overcoming challenges like patient recruitment.

Bimatoprost and clobetasol are both effective for scalp hair loss, but bimatoprost works faster, has fewer side effects, and grows more colored hair.

Oral and topical finasteride are effective and safe for treating female hair loss.